Brian Rini, MD, FASCO
Brian I. Rini, MD, FASCO, is Ingram Professor of Medicine and Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and co-host of The Uromigos podcast.
Articles by Brian Rini, MD, FASCO
In the final segment of a debate series, Brian Rini, MD, and Monty Pal, MD, debate RCC adjuvant therapeutic options.
The panel shares interesting clinical trial data in development, including CONTACT-03, TiNivo-2, and more.
The panel discusses triplet combinations in development for RCC.
The panel discusses the disappointing results of the COSMIC-313 trial.
In the second segment of a debate series, Drs. Rini and Pal address kidney cancer clinical trials of interest.
The panel discusses treatment-related toxicities and when to consider stopping treatment.
In a debate series between Brian Rini, MD, and Monty Pal, MD, they discuss frontline RCC treatment options.
The panel compares three treatment regimens.
The panel discusses the CheckMate 8Y8 clinical trial.
The panel discusses which patients in their practices would be candidates for ipilimumab/nivolumab combination.
The panel discusses monotherapy treatment for RCC.
The panel discusses how they each approach debulking nephrectomy in their RCC patients.
Dr. Rini discusses front-line immuno-oncology (IO)-based clinical trials in metastatic renal cell carcinoma.
Dr. Rini is joined by a panel of RCC experts to discuss patient characteristics that impact treatment selection.
670 Madison Ave.
Manalapan, NJ 07726